References
San Martino A, Perramon X. Phishing secrets: History, effects, and countermeasures. International Journal of Network Security. 2010;11:163–71.
Huang H, Tan J, Liu L. Countermeasure techniques for deceptive phishing attack. In: New Trends in Information and Service Science; 2009: 636–641. doi: 10.1109/NISS.2009.80
Jalalian M, Mahboobi H. Hijacked journals and predatory publishers: Is there a need to re-Think how to assess the quality of academic research? Walailak J Science and Technol. 2014;11:389–94.
Dadkhah M, Sutikno T, Jazi, Stiawan D. An introduction to journal phishings and their detection approach. TELKOMNIKA Telecommunication, Computing, Electronics and Control. 2015;13:373–80.
References
Sundel RP. Kawasaki disease. Rheum Dis Clin North Am. 2015;41:63–73.
Turnier JL, Anderson MS, Heizer HR, Jone PN, Glodé MP, Dominguez SR. Concurrent respiratory viruses and Kawasaki disease. Pediatrics. 2015;136:e609–14.
Jagadeesh A, Krishnamurthy S, Mahadevan S. Kawasaki disease in a 2-year-old child with dengue fever. Indian J Pediatr. 2016;83:602–3.
Principi N, Rigante D, Esposito S. The role of infection in Kawasaki syndrome. J Infect. 2013;67:1–10.
Abrams JY, Weintraub ES, Baggs JM, Mccarthy NL, Schonberger LB, Lee GM, et al. Childhood vaccines and Kawasaki disease, vaccine safety datalink, 1996-2006. Vaccine. 2015;33:382–7.
References
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.
Dale RC, Brilot F, Banwell B. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica and multiple sclerosis. Curr Opin Neurol. 2009;22:233–40.
Ghezzi A, Deplano V, Faroni J, Grasso MG, Liguori M, Marrosu G, et al. Multiple sclerosis in childhood: Clinical features of 149 cases. Mult Scler. 1997;3:43–6.
References
Aggarwal R, Gogtay N, Kumar R, Sahni P. The Revised Guidelines of the Medical Council of India for Academic promotions: Need for a rethink. Indian Pediatr. 2016;53:23–6.
Zbar A, Frank E. Significance of authorship position: An open-ended international assessment. Am J Med Sci. 2011;341:106–9.
Hundley V, Teijlingen EV, Simkhada P. Academic authorship: who, why and in what order? Health Renaissance. 2013;11:98–101.
Malicki M, Jeroncic A, Marusic M, Marusic A. Why do you think you should be the author on this manuscript? Analysis of open-ended responses of authors in a general medical journal. BMC Med Res Methodol. 2012;12:189.
Ray S, Shah I, Nundy S. The research output from Indian medical institutions between 2005 and 2014. Curr Med Res Pract. 2016;6:49–58.
Shen C, Bjork BC. ‘Predatory’ open access: A longitudinal study of article volumes and market characteristics. BMC Med. 2015;13:230.
References
Aggarwal R, Gogtay N, Kumar R, Sahni P. The revised guidelines of the Medical Council of India for academic promotions: need for a rethink. Indian Pediatr. 2016;53:23–6.
Principles of Transparency and Best Practice in Scholarly Publishing. http://publicationethics.org/files/Principles of Transparency and Best Practice in Scholarly Publishing.pdf. Accessed June 10, 2016.
Fleming VM, Schindler N, Martin GJ, Da Rosa DA. Separate and equitable promotion tracks for clinicianeducators. JAMA. 2005;294:1101–4.
References
Directorate General of Health Services. Office of the Drugs Controller General of India (DCGI). Notice. F No. 12-52/2004-DC (Part I). Available from: http://www.dfda.goa.gov.in/images/uploads/ale_not.pdf. Accessed May 16, 2016.
Directorate General of Health Services. Office of the Drugs Controller General of India (DCGI). Notice. F No. 12-52/2004-DC (Part I). Available from: http://www.cdsco.nic.in/writereaddata/AVASTIN.pdf. Accessed May 15, 2016.
World Health Organization. WHO Model List of Essential Medicines. 19th list (April 2015) (Amended June 2015). Available from: http://www.who.int/selection_medicines/committees/expert/20/EML_2015_FINAL_amended_JUN2015.pdf?ua=1. Accessed May 15, 2016.
Jain S, Saini SS, Chawla D, Kumar P, Dhir S. Off-label use of drugs in neonatal intensive care units. Indian Pediatr. 2014;51:644–6.
Jobanputra N, Save SU, Bavdekar SB. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU). Int J Risk Saf Med. 2015;27:113–21.
References
Yewale VN. IAP-ICMR call to action to tackle the antimicrobial resistance. Indian Pediatr. 2014;51:437–9.
Leung E, Weil DE, Raviglione M, Nakatani H. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ. 2011;89:390–2.
Bedi N, Gupta P. Antimicrobial stewardship in pediatrics: An Indian perspective. Indian Pediatr. 2016;53:293–8.
Indian Network for Surveillance of Antimicrobial Resistance (INSAR) group, India. Methicillin resistant Staphylococcus aureus (MRSA) in India: Prevalence and susceptibility pattern. Indian J Med Res. 2013;137:363–9.
Senthilkumar K, Biswal N, Sistla S. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in children. Indian Pediatr. 2015;52:31–3.
McConeghy KW, Bleasdale SC, Rodvold KA. The empirical combination of vancomycin and a â-lactam for Staphylococcal bacteremia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013;57:1760–5.
Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2003;36:1418–23.
Wong D, Wong T, Romney M, Leung V. Comparative effectiveneßs of ß-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. Ann Clin Microbiol Antimicrob. 2016;15:27.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Dadkhah, M., Bianciardi, G., Prashanth, G.P. et al. Correspondence. Indian Pediatr 53, 1027–1033 (2016). https://doi.org/10.1007/s13312-016-0983-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-016-0983-0